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Background: Abnormal Savda Munziq (ASMq) is a herbal preparation used in Traditional Uighur Medicine for the
treatment cancer. The polyphenol is main compounds contained in ASMq preparation responsible for anticancer
effect of ASMq.
Methods: In this study,Real-time quantitative Polymerase Chain Reaction (RT-PCR) assay, MTT assay and flow cytometry
were used to investigate the effect of polyphenol of ASMq on cell viability and the potential of the phenolic rich extracts
of ASMq to induce apoptosis in human cervical cancer cells SiHa and its effects on telomerase activity were investigated.
Cellular morphological change was observed by phase contrast microscopy. The MTT cell viability data revealed that
treatment with phenolic rich extracts at 75 ~ 175 μg/ml significantly inhibited the viability and proliferation of cells, and
these effects occurred in a concentration-dependent manner and time dependent manner (P < 0.01).
Results: The phenolic rich extracts can induce apoptosis of SiHa cells, can increase the apoptosis rate in a concentration-
dependent manner and time dependent manner (P < 0.01). Growth inhibition and apoptosis induction by phenolic rich
extracts treatment on SiHa cells was associated with down-regulation of anti-apoptotic Bcl-2 expression and telomerase
(P < 0.05) and Survivin expression. In addition, phenolic rich extracts exerted a dose-dependent induction of FHIT
expression.
Conclusion: These results suggest that phenolic rich extracts may have anti-tumor effects in human cervical cancer
through cytotoxicity, apoptosis-inducing properties and telomerase activity.
Keywords: Phenolic rich extracts of ASMq, Human cervical cancer, SiHa cells, Apoptosis, TelomeraseBackground
Cervical cancer is one of the most common cancers
among women worldwide, second only to breast cancer,
and disproportionately affects women in developing
countries [1,2]. Although the worldwide incidence has
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unless otherwise stated.cervical screening programs, it is still the second most
common gynecological malignancy. Furthermore, the
number of cervical cancer mortality cases in China is
among the highest in the world [3].
Cancer is a multifactorial and multistep disease caused
by the accumulation of multiple hits which involves gen-
etic and epigenetic alterations leading to aberrant expres-
sion of genes involved in initiation, progression and
promotion of carcinogenesis [4]. It is now well accepted
that apoptosis is a physiological phenomenon that plays
an important role in the regulation of tissue developmenthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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aged cells. Apoptosis is tightly regulated by a number of
gene products that promote or block cell death at differ-
ent stages. Deregulation of apoptosis has been shown to
contribute to the pathogenesis of a number of human dis-
eases including cancer [5,6]. There are apparently many
factors that have been demonstrated to be critical in the
regulation of apoptosis, including Bcl-2 family, FHIT and
Survivin, involved in the apoptotic process through the
expression of genes, and the characterization of the func-
tion of these gene products will help to define the process
of cell death at the molecular levels [7-9].
Telomeres are essential units that prevent the loss of
genetic information. Telomere dysfunction in turn in-
duces a permanent proliferation arrest known as senes-
cence and cell death [10]. Telomerase plays a critical
role in cell immortality and tumor formation, it has been
suggested that telomerase reactivation is a rate-limiting
step in cellular immortality and carcinogenesis, and that
telomerase repression can act as a tumor-suppressive
mechanism [11]. Studies have indicated that activation
of telomerase enzyme and telomere stabilization is an
important step in tumorigenesis. Inhibition of telomer-
ase activity results in the shortening of telomeres and fi-
nally leads to the crisis state resulting in apoptosis [12].
A connection between telomerase activity and resistance
to apoptosis has also been established [13].
More than 80% of the world’s population makes use of
complementary and alternative medicines which include
herbalism and botanical medicines [14]. Traditional Medi-
cine appears to play an important role in human health
and in the development of certain diseases, especially
cancer. Strong and consistent epidemiological evidences
suggest that a diet enriched with naturally occurring
substances significantly reduces the risk for many can-
cers. Many drugs used for the treatment of cancer have
been discovered from medicinal plants [15]. A major
group of these products include pigments, vitamins,
phenolic lactones, flavonoids, tannins and alkaloids
[16,17]. One group of promising phytochemicals is
polyphenols that inhibit carcinogenesis in several
models [18]. The effects of dietary phenolic compound are
of great interest currently due to their antioxidative and pos-
sible anticarcinogenic activities. Flavonoids and other phenolic
compounds derived from fruits and berries have been
shown to induce apoptotic pathways and to suppress
proliferation of various types of cancer cells [19-22].
Abnormal Savda Munziq (ASMq), one of the Uighur
medicinal herbal preparations, is widely distributed in
the Xinjiang region of China. It has long been used in
Traditional Uighur Medicine for the treatment of several
diseases such as cancer, diabetes, cardiovascular diseases
or chronic asthma [23]. Recent studies have shown that
phenolic compound of Abnormal Savda Munziq (ASMqp)can significantly inhibit the growth and viability of Hep
G2 human hepatoma cell line [24]. ASMqp has also been
reported to scavenge free radicals [25]. In addition, some
species included in ASMq were reported to show in vitro
inhibitory activity on different tumor cell lines [26-31]. A
phenolic fraction with high anti-proliferative activity on
HL-60 cells was obtained from ASMq through the
bioassay-guided fractionation process. The results of
the cell viability assay, quantification assay and the TLC
and LC-MS analyses on ASMq fractions revealed that
the main bioactive components with anti-proliferative
activity against HL-60 cell line could be phenolic com-
pounds [32].
The present work was undertaken to investigate the
underlying mechanism involved in the induction of
apoptosis by phenolic compounds from ASMqp in hu-
man cervical cancer cell SiHa with special emphasis on
its role in regulation of apoptosis, including expression
of Bcl-2 family, FHIT and Survivin, as well as inhibiting
telomerase activity. The primary objective of our study is
to establish a possible association of apoptosis with sup-
pression of telomerase activity. The present study was
undertaken to investigate whether the combinatorial
chemopreventive effect of phenolic-rich extract from
ASMq on human cervical cancer cell SiHa is mediated
by decreasing cell proliferation, inducing apoptosis, the
apoptosis-associated proteins Bcl-2 family, FHIT and
Survivin, and inhibiting telomerase activity.Methods
Plant materials
Pobumuguo (fruits of C. dichotoma), Niushecao (whole
plant of A. italica), Gancao (root of G. uralensis),Tiexianjue
(whole plant of A. capillus-veneris), Dijincao (whole plant
of E. humifusa), Hongzao (fruits of Z. jujuba), Xunyicao
(aerial part of L. angustifolia), Xiaohuixiang (fruits of F.
vulgare), Mifenghua (whole plant of M. officinalis) and
Citang (sugar secretion from A. pseudoalhagi) were pur-
chased from Xinjiang Hospital of Traditional Uighur
Medicine, Urumqi, China in September 2007. The plant
material used was unprocessed.Preparation of abnormal Savda Muziq (ASMq)
ASMq was prepared according to this procedure. The
mixture was decocted in boiling water in a ratio of 1:10
(w/v) for 3 h. After filtration, the residue was reex-
tracted for 3 h, two times in the same volume of boiling
water. The resulting crude extract was filtered, evapo-
rated to dryness under reduced pressure and pulver-
ized. The obtained powder was used for this study. The
yield was 39.9% (w/w) with respect to the total mass of
dry materials.
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ASMq
The protocol used to obtain polyphenolic rich extracts
from bean samples was based on the previously method
[32]. Dry extract of ASMqp (1500 g) was dissolved in
1050 mL hot H2O (60°C) and filtered.1.5 volumes of
95% EtOH were added; the mixture was stirred for
20 min, and then allowed to stand for 24 h. The result-
ing supernatant layer was filtered, concentrated under
reduced pressure to 350 mL and subjected to column
chromatography (125 cm × 5 cm) on polyamide resin.
The column was eluted first with H2O dest. (3BV),
followed by 60% EtOH. The fraction eluted with H2O
dest was discarded, while the fraction eluted with 60%
EtOH was evaporated under reduced pressure to dryness
to obtain phenolic rich extract (15.4 g). The yield (w/w)
of polyphenol fraction was 3.49% with respect to the dry
weight of ASMq.
Cell lines and culturing
Human Cervical cancer SiHa cells were obtained from
the Shanghai Cell Bank of Chinese Academy of Sciences
and maintained in our laboratory. The cells were grown
as monolayers in DMEM medium supplemented with
2 m Mglutamine, antibiotics (100 U/ml penicillin A and
100 U/ml streptomycin), and 10% heat-inactivated fetal
bovine serum (FBS), and maintained at 37°C in a hu-
midified incubator containing 5% CO2 + 95% air. All cells
were passed twice weekly and routine examination was
also done for mycoplasma contamination. Cells in loga-
rithmic growth phase were used for further experiments.
Chemicals and reagents
DMEM medium and fetal calf serum (FCS) were pur-
chased from GIBCO compnay (USA), The apoptosis de-
tection kit was from Becton Dickinson and Company
(San Jose, CA, USA). 3-(4,5-dimethyl-2-thiazyl)-2, 5-
diphenyl-2H-tetrazolium bromide (MTT), tyripsin and
DMSO were from Amresco (USA), fix and perm kit was
from Caltag laboratories, Beckman. Coulter USA), PE
Anti-Bcl-2 Antibody was from Invitrogen Co., Ltd.
(Shanghai, China), FITC Anti- Polyclonal antibodies for
polymerase was from Bioss Technology Development
Co., Ltd., (Beijing China). Other chemicals were com-
mercially available reagent grade or ultrapure grade.
Method
MTT assay
Cytotoxicity was measured by MTT assay. SiHa cells
(1 × 105/well) in 100 ul DMEM were plated in 96-well
plates and incubated for 24 h to allow the cells to attach,
before treatment extract. Extract was dissolved in DMSO
and the cells were treated with 75 μg/ml, 100 μg/ml,
125 μg/ml, 150 μg/ml, 175 μg/ml concentration of extractfor 24, 48,72 h and 96 h, Cells treated with 0.1% DMSO
served as a negative control. After incubation for specified
time at 37°C in a humidified incubator, 20 ul MTT (5 mg/
ml in PBS) was added to each well and incubated for 4 h,
after which the plate was centrifuged at 1800 g for 5 min
at 4°C. After careful removal of the medium, 150 ul of
buffered DMEM was added to each well, and plates were
shaken. The absorbance was recorded on a microplate
reader (Bio Rad Laboratories, Hercules, CA, USA) at the
wavelength of 490 nm. The effect of each compound on
growth inhibition was assessed as percent cell viability
where vehicle-treated cells were taken as 100% viable.
The experiments were performed in triplicate and re-
sults were described as average of A. For morphological
study, the cells were treated with WECM for 48 h and
directly photographed with an inverted microscope.
Assessment of apoptosis by flow cytometric analysis
Cytotoxicity was measured by MTT assay. Cells were
counterstained with PI as a vital dye to distinguish be-
tween apoptotic (annexin V positive, PI negative) and
necrotic (annexin V positive, PI positive) cells. SiHa cells
(1 × 105/well) in 2 ml DMEM were plated in 6-well
plates and incubated for 24 h to allow the cells to attach,
before treatment extract. Extract was dissolved in
DMSO and the cells were treated with 75 μg/ml,
100 μg/ml, 125 μg/ml, 150 μg/ml concentration of ex-
tract for 48 h, Cells treated with 0.1% DMSO served as a
negative control (0 μg/ml) and digested for 4 minutes
with 0.25% trypsin, collect the cells was washed with 4°C
PBS twice, centrifugation at 1500 r/min for 10-minute,
were resuspended in 100 ul of binding buffer and incu-
bated with 5 μl FITC-conjugated Annexin-V and 5 μl PI
for 15 minutes at room temperature in the dark, add
400 μl binding buffer each tube, and were then immedi-
ately analyzed by flow cytometry (FACScan’BD Immuno-
cytometry Systems, Mountain View, CA). A minimum
of 10,000 events was acquired for each sample.
Flow cytometric analysis of bcl-2 and telomeres
Cytotoxicity was measured by MTT assay. Cells were
counterstained with PI as a vital dye to distinguish be-
tween apoptotic (annexin V positive, PI negative) and nec-
rotic (annexin V positive, PI positive) cells, respectively.
SiHa cells (1 × 105/well) in 2 ml DMEM were plated in 6-
well plates and incubated for 24 h to allow the cells to at-
tach, before treatment extract. Extract was dissolved in
DMSO and the cells were treated with 75 μg/ml, 100 μg/
ml, 125 μg/ml, 150 μg/ml concentration of extract for
48 h, Cells treated with 0.1% DMSO served as a nega-
tive control (0 μg/ml). and digested for 4 minutes with
0.25% trypsin, collect the cells was washed with 4°C
PBS twice, centrifugate at 1500 r/min for 10-minute,
discard supernatants. Then the cells were resuspended
Table 1 The primers used in this study for
semiquantitative RT-PCR assay
Gene Primer primer sequence
β-actin F: 5′- TGGCACCCAGCACAATGAA-3′
R: 5′- CTAAGTCATAGTCCGCCTAGAAGCA-3′
FHIT F: 5′- GCAGCTCTGCGGGTCTACTTTC-3′
R: 5′- TCTTCAAACTGGTTGGCAATAGCTC-3′
Survivin F: 5′- GTCCGGTTGCGCTTTCCTT-3′
R: 5′- CGCAGTTTCCTCAAATTCTTTCTTC-3′
F: Forward primer, R: Reverse primer.
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flow cytometry test tube, one tube served as a negative con-
trol, one tube served as a assay tube, SiHa cells is 1 ~ 5 ×
105 each tube, and add each tube Fix&Perm reagent 1 100
ul, shaked and then standing for 15 min at room
temperature, add 4 ml PBS, centrifugated at 1500 r/min
for 5 min, discard supernatants. Then add each tube Fix
&Perm reagent 2 100 ul and standing for 15 min at
room temperature. Then add Anti-Telomerase (TE)/FITC
antibody 2 ul and anti-Bcl/PE antibody to test tube, shaken
slightly, standing for 15 min at room temperature in the
dark. Then add 4 ml PBS to each tube, centrifugate at
1500 r/min for 5 min, discard supernatants. The cells were
resuspended in 1 mlul of PBS, and were then immediately
analyzed by flow cytometry (FACScan’BD Immunocytome-
try Systems, Mountain View, CA). A minimum of 10,000
events was acquired for each sample. Data were analyzed
using the Flow Jo software (Treestar, San Carlos, CA).
Measurement of FHIT and Survivin expression by real-time
PCR
Following treatment for 48 h, cells grown in 60 mm
Petri dishes were washed with ice-cold PBS and 1 ml of
trizol reagent (Invitrogen Inc, Carlsbad, CA) was added
and flushed gently to disrupt the cells, the lysates were
collected and mixed with 200 μl of chloroform by inver-
sion. The tubes were then centrifuged at 10,000 rpm for
15 min at 4°C. The aqueous phases from the tubes were
collected and the RNA precipitated using 700 μl of iso-
propanol and centrifuged at 12,000 rpm for 10 min at 4°C.
The pellets were washed twice with 75% ethanol, centri-
fuged at 7500 rpm for 10 min at 4°C and air-dried for
about 20–40 min. The pellets were resuspended in 20 μl
of DEPC treated water. The purity of RNA was checked
by OD260/280 of RNA samples (N1.8). The quality of the
RNA was analyzed by agarose gelelectrophoresis. Reverse
transcription was then performed on the 1 μg of total
RNA using the ExScript RT reagent Kit (TaKaRa).Isolated
total RNA (1 μg) was reverse-transcribed to cDNA in a re-
action mixture containing 4 μl of 5 × reaction buffer, 1 μl
of PrimeScriptTM RT Enzyme Mix, 1 μl of Oligo dT Pri-
mer (50 μM), 1 μl of Random 6 mers (100 μM) and Rnase
Free dH2O, in a total volume up to 20 μl. The reaction
mixture was incubated at 37°C for 45 min and the reaction
was terminated by heating at 85°C for 5 sec. The result-
ant cDNA was diluted 10 times and use for RT-PCR
amplification.
All oligonucleotide primers were purchased from Sigma
Genosys, India. Details about the primers are given in
Table 1. Quantitative real-time RT-PCR for the FHIT and
Survivin mRNA was performed on an ABI PRISM127100
Sequence Detection System (Applied Biosystems, Foster
City, CA, USA) using SYBR Green Master Mix (Takara
Biotechnology Co. Ltd., Dalian, China). For normalization,glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used. The final reaction volume was 20 μl, containing
10 μl × SYBR12 Premix ExTaqTM, 0.5 μl Forward Primer
(10 μM), 0.5 μl Reverse Primer(10 μM) 2.0 μl cDNA and
7 μl dH2O. Cycling conditions were as follows: initial de-
naturation at 95°C for 10 s, followed by 40 cycles of 60°C
for 30 s and 59°C for 31 s. After PCR, a dissociation curve
analysis was done. Relative gene expression was calculated
using the 2−△△CT method with pooled cDNA from all
samples as a reference.Statistical analysis
All values were presented as means ± SEM and evaluated
for statistical significance with one-way ANOVA followed
by Duncan’s multiple range test. P values less than 0.05
were considered significant.Results
Cytotoxicity and inhbiitory activity of ASMq extract on
cell morphology and cell proliferation
To evaluate the effects of ASMp on cell proliferation, we
investigated the effects of ASMqp on cell growth of Siha
cells. Cells were exposed to increasing doses of ASMq ex-
tract for 24 h, 48 h, 72 h and 96 h cell viability was deter-
mined by the MTT assay. As shown in Figure 1, cell
viabilities of Siha were markedly decreased after exposure
to ASMq extract in a dose-and time-dependent manner.
The proliferation of Siha cells was reduced by about 50%
after 24 h of exposure to 150 μg/ml and 175 μg/m of ASMq
extract. The inhibition ratio is 83.55% after 96 h of expos-
ure to 175 μg/ml of ASMq extract. The IC50 is 134.51 ±
2.55 μg/ml after 48 h of exposure to of ASMq extract. In
addition, direct observation using an inverted microscope
revealed that numerous morphological changes occurred in
cells treated with of ASMq extract. In particular, cell shrink-
age, condensation of cytoplasm, and formation of cytoplas-
mic filaments, chromosomal condensation and formation
of apoptotic bodies appeared in a concentration-dependent
manner after ASMq extract treatment. After exposed to
120 μg/mL of ASMq extract for 24 h, cells began to shrink
with diminished cytoplasm and gradually detached from
Figure 1 Morphologic changes of Siha cells treated with phenolic rich extracts of ASMq and inhibition of the cell growth of phenolic
rich extracts of ASMq on Siha cells. A: Cells were incubated with varying concentrations of phenolic rich extracts of ASMq for 48 h, observed
and photographed with an inverted microscope. (magnification × 200). B Inhibitory effect of ASMp on proliferation of of Siha cells in dose-dependent
manner and time dependent manner. Mean absorbance observed in the MTT assay after treatment of 24, 48 72 h and 96 h with 75 ug/ml, 100 ug/ml,
125 ug/ml and 150 ug/ml of ASMqp. Growth inhibition was calculated relative to negative control, and the data represents the mean ± SE of
three experiments each conducted in triplicate.
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yopyknosis appeared (Figure 1).
Apoptosis is induced by ASMqp in Siha cells
The results of apoptosis ratio found after 24 h of treatment
with 0, 75, 100, 125 and 150 ug/ml of of ASMq extract aregiven in Figure 2, where we can see that different concentra-
tion of of ASMq extract tested can induce apoptosis. There
were significant differences observed in the proportion of of
ASMq extract Annexin V-positive cells between treated and
vehicle-treated cell groups. The three independent measure-
ments made after 48 h of exposure to 150 ug/mL of of
Figure 2 Apoptosis-inducing, inhibition of Bcl-2 expression and telomerase activity by phenolic rich extracts of ASMq. Extracts of ASMq
treatment in Siha cells during treatment with 75 ug/ml, 100 ug/ml, 125 ug/ml and 150 ug/ml of extracts of ASMq for 48 h. A: The cells were sampled
and stained with Annexin V-FITC/PI to quantify the degree of apoptosis induced by ASMqp, the cells were evaluated and analyzed by flow cytometry.
Values represent mean ± S.D. (n = 10000). B, C: The cells incubated with Anti-Telomerase (TE)/FITC antibody and anti-Bcl/PE antibody after treatment
with ASMqp, and were then analyzed by flow cytometry. D: Values represent mean ± S.D. (n =10000).
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(Figure 2A and D). There were 14.20 ± 4.06%, 21.70 ± 1.84%,
39.13 ± 3.68%, 62.73 ± 4.49% Annexin V-positive cells among
the cells treated with 75, 100, 125 and 150 ug/ml of ASMq
extract respectively for 48 h, and compared to the vehicle-
treated cells (5.39 ± 1.31%), indicating that ASMqp induced
apoptosis in the Siha cells in a dose-dependent manner.ASMqp down-regulated expression of Bcl-2 and telomerase
activity
To explore the possible mechanism by which of ASMq
extract induced apoptosis in Siha cells, the expression of
both Bcl-2 and telomeres activity was analyzed by flow
cytometry. As indicated in Figure 2B, C and D). Signifi-
cant changes in expression of Bcl-2 and telomeres were
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of ASMq extract for 48 h, of ASMq extract markedly
down-regulated the expression levels of Bcl-2 and tel-
omerase in a concentration-dependent manner.
ASMqp regulate of expression of FHIT and Survivin
To investigate the mechanism responsible for the apop-
tosis induced by ASMq extract in Siha cells, we analyzed
the FHIT and Survivin gene expression by RT-PCR analys
is using specific primers (Table 1). As shown in Figures 3
and 4. the gene expression of FHIT up-regulated in Siha
cells after treatment by ASMq extract for 48 h. This indi-
cated that there was increase in the FHIT/β-actin ratio.
But the gene expression of Survivin down-regulated in
dose dependently in Siha cells after treatment by f ASMq
extract for 48 h. This indicated that there was decrease in
the Survivin/β-actin ratio.
Discussion
Consistency in both composition and biological activity are
critical requirements for safe as well as effective develop-
ment and use of medicinal herbs. Flavonoids are yphenolic
compounds that occur naturally in various plant species.
They are utilized mainly as a source of starting material in
the pharmaceutical and food industries and show numer-
ous biological activities of interest, for example, antioxidantFigure 3 Effect of ASMqp on expression of FHIT in Siha cells was mea
loading control. The experiment was quantified by densitometry and repr
Representative results from three independent experiments are shown. Dacapacity, anti-inflammatory action and stimulation of the
immune system [33,34]. In recent years, identification of
effective chemopreventive polyphenols in diets or dietary
supplements for human use is of much interest. Apoptosis
plays a crucial role in eliminating the mutated hyperproli-
ferating cells from the system. Thus, induction of apoptosis
in tumor cells may be considered as a protective mechan-
ism against development and progression of cancer [35].
In this work, we have demonstrated total polyphenolic
compounds of traditional Uighur medicine preparation
Abnormal Savda Munziq, in a dose-and time-dependent
manner inhibited cellular proliferation of Siha cells by
MTT assay. Morphological characterization of phenolic
rich extracts -treated cells revealed that the mode of ac-
tion of cell death is mediated through induction of apop-
tosis. Typical features of apoptosis like cell shrinkage,
cytoplasmic condensation, and formation of cytoplasmic
filaments, chromosomal condensation and formation of
apoptotic bodies of phenolic rich extracts -treated cells
clearly evident from inverted microscope study. Flow cy-
tometry analysis showed that apoptotic cells gradually in-
creased in a dose and time dependent manner after the
cells were treated with concentrations of phenolic rich ex-
tracts of ASMq for 48 h. To clarify the mechanisms of
apoptosis caused by phenolic rich extracts of ASMq, we
detected expression of the common apoptosis-dependentsured using a RT-PCR analyses, β-Actin was used as an internal
esented as the indicated expression of FHIT/β-actin ratio.
ta are expressed as means ± SD of three independent experiments.
Figure 4 Effect of ASMqp on expression of Survivin in Siha cells was measured using a RT-PCR analyses, β-Actin was used as an
internal loading control. The experiment was quantified by densitometry and represented as the indicated expression of Survivin/β-actin
ratio. Representative results from three independent experiments are shown. Data are expressed as means ± SD of three independent
experiments.
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survivin expression. Flow cytometry and RT-PCR analysis
revealed that bcl-2 expression, telomerase activity and sur-
vivin expression were down-regulated remarkably while
FHIT expression up-regulated.
Apoptosis plays a crucial role in eliminating the mu-
tated hyperproliferating cells from the system. Recently,
inducers of apoptosis have been used in cancer therapy
and activation of apoptosis pathways is a key mechanism
by which cytotoxic drugs kill tumor cells and now been
considered as an important method of assessment for
the clinical effectiveness of many anti-tumor drugs [36].
Apoptosis is tightly regulated by a number of gene prod-
ucts that promote or block cell death at different stages.
One of the major genes that regulates apoptosis is the
Bcl-2family. It has been reported that Bcl-2 members
protect against multiple signals that lead to cell death,
whereas Bax members induce apoptosis indicating that
Bcl-2 family regulates a common cell death pathway and
functions at a point where various signals converge
[37,38]. The Bcl-2 family is the most extensively studied
and perhaps the most important target for chemopre-
ventive agents [39,40].
Telomerase is a specialized reverse transcriptase that
synthesizes and preserves telomeres, thereby playing a
key role in regulating the lifespan of cell proliferation.
Telomerase activity is critically involved in cell develop-
ment, aging and tumorigenesis, and is required for self-
renewal and proliferative expansion in a number of cell
types, including most cancer cells [41]. Most human
cancers have short telomeres and express high levels of
telomerase activity as compared to normal tissue [42]. It
has been thought that telomerase activation might be acritical step in cellular immortalization. According to the
telomere hypothesis for replicative senescence, genetic
experiments using an ineffective form of human tel-
omerase have demonstrated that telomerase inhibition
can result in telomere shortening followed by growth ar-
rest and apoptosis [43,44], supporting the potential use
of telomerase inhibition for cancer therapy. Inhibition of
telomerase results in telomere shortening, repressed
proliferation and altered cell cycle that result in apop-
tosis [45]. Telomerase has been shown in several studies
to be a potentially sensitive biomarker for early cancer
screening [46]. Also, it is believed that the modification of
telomerase activity may be a potential therapeutic modal-
ity for the treatment of human cancers. It was reported
that the over-expression of Bcl-2 in human cervical and
colorectal carcinoma cells resulted in an increased tel-
omerase activity and a resistance to apoptosis, indicating
a link between Bcl-2 expression and telomerase activity in
human cancer cells [47]. As shown in Figure 2, ASM ex-
tract induced a concentration-dependent inhibition of tel-
omerase activity with down-regulation of the expression
of Bcl-2. The results suggested that repression of telomer-
ase activity by KRG extract was associated with down-
regulation of Bcl-2 expression.
FHIT is a tissue-specific tumor suppressor gene, and
its inactivity is often associated with the occurrence and
development of cancer, especially epithelial cancer, in-
cluding cervical carcinomas [48]. It has been reported
that re-expression of FHIT in a variety of human cell
lines results in growth inhibition and apoptosis induc-
tion. Previous studies reported that a reduction of FHIT
was positively correlated with the rate of distant metas-
tases and worse prognosis. Over-expression of FHIT is
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examined [49]. Furthermore, FHIT overexpression pro-
duces alteration in cell cycling properties, as well as reduc-
tion of the tumorigenic potential in nude mice [50]. FHIT
plays a critical role in FHIT-induced apoptosis, occurring
through inactivation of the Survivin-Caspase signal path-
way in the development of human CRC. Restoration of
FHIT expression induced apoptosis in all FHIT-negative
cell lines and SiHa cells among cervical carcinomas [51].
Results indicate that paclitaxel-induced apoptosis en-
hanced by FHIT expression in lung cancer cells might be
associated with modulation of Bcl-2-caspase signaling [52].
Therefore, FHIT replacement or therapeutic activation
of the FHIT pathway could contribute to cancer preven-
tion. Survivin is a member of a new protein family
known as the ‘inhibitors of apoptosis’, blocks apoptosis
by interacting with and inactivating the proapoptogenic
mitochondrial protein SMAC (second mitochondria-
derived activator of caspase) and by inhibiting caspases
[53]. It is present during embryonic development but ab-
sent from terminally differentiated adult tissues, and is
prominently expressed in transformed cell lines and
most tumour types [54], including cervical cancer [55].
Recently, survivin has attracted the attention of scien-
tists as a candidate biomarker because of its unique dis-
tribution. Some studies have demonstrated that FHIT
activation is associated with inactivation of the PI3K-
Akt-survivin signal pathway and increased Bcl-2 expres-
sion during in Fhit-induced apoptosis. Akt has been im-
plicated as a major factor in many types of cancer. FHIT
has been shown to modulate the Akt-survivin pathway by
inhibiting the activity of Akt, a key effector in the phos-
phatidylinositol 3-OH kinase (PI3K) pathway. In this
study, apoptotic cell death was accompanied by FHIT up-
regulation and Survivin down-regulation, suggesting the
ASMqp-induced apoptosis is probably mediated through
the Akt-survivin pathway and Bcl-2 related pathways.
Conclusions
In conclusion, the results of the present study reveal that
ASMqp inhibits Siha cell proliferation and induce apop-
tosis through the proapoptotic and antiapoptotic genes.
This provides a molecular basis for understanding the
chemopreventive effect of ASMqp that might be ideal
candidates to induce effective apoptosis in human cer-
vical cancer cells. However, presently the detailed mech-
anism underlying the antiproliferative role of ASMqp
has been delineated in case of Siha cells only. More work
is required to find out the precise role of phenolic rich
extracts of ASMq in different types of cervical cancer a
cells to understand whether the action of these polyphe-
nols is cell line specific general mechanism. These obser-
vations will add new light in the field of developing
therapeutic strategies for cancer in the near future inUighur Medicne. To our knowledge, this is the first re-
port of the induction of apoptosis and its mechanism is
induced by phenolic rich extracts of ASMq, an import-
ant constitution in the ASMq.
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